vs
Side-by-side financial comparison of AMICUS THERAPEUTICS, INC. (FOLD) and INTERFACE INC (TILE). Click either name above to swap in a different company.
INTERFACE INC is the larger business by last-quarter revenue ($349.4M vs $185.2M, roughly 1.9× AMICUS THERAPEUTICS, INC.). INTERFACE INC runs the higher net margin — 7.0% vs 0.9%, a 6.1% gap on every dollar of revenue. On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs 4.3%). INTERFACE INC produced more free cash flow last quarter ($28.6M vs $16.0M). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs 9.8%).
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
Interface, Inc., headquartered in Atlanta, Georgia, is a global manufacturer of commercial flooring. The company sells modular carpet tiles, luxury vinyl tile, and Nora brand rubber flooring.
FOLD vs TILE — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $185.2M | $349.4M |
| Net Profit | $1.7M | $24.4M |
| Gross Margin | 85.7% | 38.6% |
| Operating Margin | 8.6% | 10.1% |
| Net Margin | 0.9% | 7.0% |
| Revenue YoY | 23.7% | 4.3% |
| Net Profit YoY | -88.5% | 12.1% |
| EPS (diluted) | $0.00 | $0.41 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $185.2M | $349.4M | ||
| Q3 25 | $169.1M | $364.5M | ||
| Q2 25 | $154.7M | $375.5M | ||
| Q1 25 | $125.2M | $297.4M | ||
| Q4 24 | $149.7M | $335.0M | ||
| Q3 24 | $141.5M | $344.3M | ||
| Q2 24 | $126.7M | $346.6M | ||
| Q1 24 | $110.4M | $289.7M |
| Q4 25 | $1.7M | $24.4M | ||
| Q3 25 | $17.3M | $46.1M | ||
| Q2 25 | $-24.4M | $32.6M | ||
| Q1 25 | $-21.7M | $13.0M | ||
| Q4 24 | $14.7M | $21.8M | ||
| Q3 24 | $-6.7M | $28.4M | ||
| Q2 24 | $-15.7M | $22.6M | ||
| Q1 24 | $-48.4M | $14.2M |
| Q4 25 | 85.7% | 38.6% | ||
| Q3 25 | 88.5% | 39.4% | ||
| Q2 25 | 90.2% | 39.4% | ||
| Q1 25 | 90.7% | 37.3% | ||
| Q4 24 | 90.1% | 36.5% | ||
| Q3 24 | 90.6% | 37.1% | ||
| Q2 24 | 91.1% | 35.4% | ||
| Q1 24 | 87.7% | 38.1% |
| Q4 25 | 8.6% | 10.1% | ||
| Q3 25 | 20.3% | 14.6% | ||
| Q2 25 | -6.1% | 13.9% | ||
| Q1 25 | -6.3% | 7.8% | ||
| Q4 24 | 10.7% | 8.8% | ||
| Q3 24 | 15.3% | 12.3% | ||
| Q2 24 | 11.8% | 11.0% | ||
| Q1 24 | -25.1% | 8.4% |
| Q4 25 | 0.9% | 7.0% | ||
| Q3 25 | 10.2% | 12.7% | ||
| Q2 25 | -15.8% | 8.7% | ||
| Q1 25 | -17.3% | 4.4% | ||
| Q4 24 | 9.8% | 6.5% | ||
| Q3 24 | -4.8% | 8.3% | ||
| Q2 24 | -12.4% | 6.5% | ||
| Q1 24 | -43.9% | 4.9% |
| Q4 25 | $0.00 | $0.41 | ||
| Q3 25 | $0.06 | $0.78 | ||
| Q2 25 | $-0.08 | $0.55 | ||
| Q1 25 | $-0.07 | $0.22 | ||
| Q4 24 | $0.05 | $0.38 | ||
| Q3 24 | $-0.02 | $0.48 | ||
| Q2 24 | $-0.05 | $0.38 | ||
| Q1 24 | $-0.16 | $0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $293.5M | $71.3M |
| Total DebtLower is stronger | $392.7M | $181.6M |
| Stockholders' EquityBook value | $274.2M | $640.7M |
| Total Assets | $949.9M | $1.2B |
| Debt / EquityLower = less leverage | 1.43× | 0.28× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $293.5M | $71.3M | ||
| Q3 25 | $263.8M | $187.4M | ||
| Q2 25 | $231.0M | $121.7M | ||
| Q1 25 | $250.6M | $97.8M | ||
| Q4 24 | $249.9M | $99.2M | ||
| Q3 24 | $249.8M | $115.6M | ||
| Q2 24 | $260.1M | $94.2M | ||
| Q1 24 | $239.6M | $89.8M |
| Q4 25 | $392.7M | $181.6M | ||
| Q3 25 | $392.0M | $307.8M | ||
| Q2 25 | $391.3M | $304.4M | ||
| Q1 25 | $390.7M | $302.9M | ||
| Q4 24 | $390.1M | $302.8M | ||
| Q3 24 | $389.5M | $337.9M | ||
| Q2 24 | $388.9M | $387.6M | ||
| Q1 24 | $388.4M | $391.8M |
| Q4 25 | $274.2M | $640.7M | ||
| Q3 25 | $230.4M | $621.0M | ||
| Q2 25 | $204.3M | $575.0M | ||
| Q1 25 | $193.6M | $513.1M | ||
| Q4 24 | $194.0M | $489.1M | ||
| Q3 24 | $178.8M | $501.6M | ||
| Q2 24 | $132.5M | $451.2M | ||
| Q1 24 | $130.7M | $428.5M |
| Q4 25 | $949.9M | $1.2B | ||
| Q3 25 | $868.8M | $1.3B | ||
| Q2 25 | $815.3M | $1.3B | ||
| Q1 25 | $789.8M | $1.2B | ||
| Q4 24 | $785.0M | $1.2B | ||
| Q3 24 | $786.6M | $1.2B | ||
| Q2 24 | $749.5M | $1.2B | ||
| Q1 24 | $721.8M | $1.2B |
| Q4 25 | 1.43× | 0.28× | ||
| Q3 25 | 1.70× | 0.50× | ||
| Q2 25 | 1.92× | 0.53× | ||
| Q1 25 | 2.02× | 0.59× | ||
| Q4 24 | 2.01× | 0.62× | ||
| Q3 24 | 2.18× | 0.67× | ||
| Q2 24 | 2.93× | 0.86× | ||
| Q1 24 | 2.97× | 0.91× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $16.3M | $49.3M |
| Free Cash FlowOCF − Capex | $16.0M | $28.6M |
| FCF MarginFCF / Revenue | 8.6% | 8.2% |
| Capex IntensityCapex / Revenue | 0.2% | 5.9% |
| Cash ConversionOCF / Net Profit | 9.62× | 2.02× |
| TTM Free Cash FlowTrailing 4 quarters | $29.8M | $121.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $16.3M | $49.3M | ||
| Q3 25 | $35.7M | $76.7M | ||
| Q2 25 | $-26.5M | $30.1M | ||
| Q1 25 | $7.8M | $11.7M | ||
| Q4 24 | $-3.9M | $38.0M | ||
| Q3 24 | $-23.0M | $76.2M | ||
| Q2 24 | $22.7M | $21.5M | ||
| Q1 24 | $-29.7M | $12.6M |
| Q4 25 | $16.0M | $28.6M | ||
| Q3 25 | $35.3M | $66.1M | ||
| Q2 25 | $-28.9M | $22.8M | ||
| Q1 25 | $7.5M | $4.3M | ||
| Q4 24 | $-4.2M | $24.4M | ||
| Q3 24 | $-23.3M | $69.7M | ||
| Q2 24 | $21.6M | $12.0M | ||
| Q1 24 | $-31.5M | $8.6M |
| Q4 25 | 8.6% | 8.2% | ||
| Q3 25 | 20.9% | 18.1% | ||
| Q2 25 | -18.7% | 6.1% | ||
| Q1 25 | 6.0% | 1.4% | ||
| Q4 24 | -2.8% | 7.3% | ||
| Q3 24 | -16.5% | 20.3% | ||
| Q2 24 | 17.0% | 3.5% | ||
| Q1 24 | -28.5% | 3.0% |
| Q4 25 | 0.2% | 5.9% | ||
| Q3 25 | 0.2% | 2.9% | ||
| Q2 25 | 1.6% | 2.0% | ||
| Q1 25 | 0.2% | 2.5% | ||
| Q4 24 | 0.2% | 4.1% | ||
| Q3 24 | 0.3% | 1.9% | ||
| Q2 24 | 0.9% | 2.8% | ||
| Q1 24 | 1.6% | 1.4% |
| Q4 25 | 9.62× | 2.02× | ||
| Q3 25 | 2.06× | 1.66× | ||
| Q2 25 | — | 0.93× | ||
| Q1 25 | — | 0.90× | ||
| Q4 24 | -0.27× | 1.75× | ||
| Q3 24 | — | 2.68× | ||
| Q2 24 | — | 0.95× | ||
| Q1 24 | — | 0.89× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
TILE
| AMS | $205.9M | 59% |
| EAAA | $143.5M | 41% |
